Apixaban returned to CVS Caremark formulary after outcry
Main Author: | Beth Waldron |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Online Access: | https://doi.org/10.1002/rth2.12774 |
Similar Items
-
Another Outcry for Artistic Relevance
by: Rob van Gerwen
Published: (2023-01-01) -
Nutritionists unimpressed by sugar lobby's outcry
by: Hagmann Michael
Published: (2003-01-01) -
Nonmedical switching of anticoagulants: The patient impact when formulary exclusions limit drug choice
by: Beth Waldron
Published: (2022-02-01) -
Henry James, Novels 1903-1911 – The Ambassadors, The Golden Bowl, The Outcry
by: Marco Trainini
Published: (2012-06-01) -
OUTCRY AND CALL FOR RELIEF: EXPERIENCES AND SUPPORT NEEDS OF PARENTS WITH NYAOPE USERS
by: Jan Masombuka, et al.
Published: (2020-02-01)